Pictet Asset Management Holding Sa Xenon Pharmaceuticals Inc. Transaction History
Pictet Asset Management Holding Sa
- $85.6 Billion
- Q2 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 1,479,491 shares of XENE stock, worth $66.5 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,479,491
Previous 1,515,426
2.37%
Holding current value
$66.5 Million
Previous $65.2 Million
11.58%
% of portfolio
0.07%
Previous 0.07%
Shares
4 transactions
Others Institutions Holding XENE
# of Institutions
222Shares Held
69.7MCall Options Held
59.7KPut Options Held
60.7K-
Avoro Capital Advisors LLC New York, NY5.67MShares$255 Million3.02% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.42MShares$199 Million1.86% of portfolio
-
Wellington Management Group LLP Boston, MA3.83MShares$172 Million0.03% of portfolio
-
Commodore Capital LP New York, NY2.75MShares$124 Million9.63% of portfolio
-
Capital World Investors Los Angeles, CA2.68MShares$121 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.8B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...